Acute Lymphoblastic Leukemia | Topics

 
Caloric and Nutrient Restrictions Positively Impacted Response for Overweight Patients With B-cell ALL
May 09, 2021

Reducing caloric and nutrient intake for patients who were overweight or obese and undergoing induction for B-cell acute lymphoblastic leukemia was feasible and improved patient response, according to an early-phase trial.

Low-Intensity Chemotherapy Without Intensified Pegaspargase Cured Most Patients With Low-Risk B-ALL
May 02, 2021

Data in the Journal of Clinical Oncology found that low-intensity chemotherapy without additional intensified pegaspargase cured almost all patients treated on the Children’s Oncology Group AALL0331 trial.

Application for Brexucabtagene Autoleucel in B-cell ALL Submitted to FDA for Consideration
April 09, 2021

CD19-directed CAR T-cell therapy brexucabtagene autoleucel will be considered by FDA for indication in adults with B-cell precursor acute lymphoblastic leukemia.